fda covid - Search News

News

COVID, FDA and Heart Risk

USA TODAY · 1h

The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides’ Dr. Diwan

SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the “Company”), comments on the new COVID Vaccine policy adopted by the US FDA. The new FDA COVID Vaccine Booster Shots policy [1] is based on the findings that the groups that benefit from repeat

U.S. News & World Report · 1h

FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines

The updated warnings highlight a rare risk of heart inflammation in teen boys and young men, CBS News reported. The warning applies to males ages 16 to 25 and is based on new data from FDA safety monitoring and a 2023 study. This includes both Pfizer's Comirnaty and Moderna's Spikevax vaccines.

FDA plans to limit COVID vaccine to only high-risk people: What Oklahomans should know

FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.

FDA, COVID-19

Roll Call · 4h

FDA won’t approve COVID shot for healthy, non-elderly population

The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials.

USA TODAY on MSN · 1d

FDA sets new COVID booster guidelines for healthy adults under 65

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

The Washington Post on MSN · 1d

FDA to limit covid shot approval to 65+, those with medical conditions

The FDA will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to green-lighting shots that have been recommended broadly to the public.

26m

Concerned about losing access to COVID boosters? Here’s how to make your voice heard.

As the Trump administration’s FDA moves to limit approval for COVID-19 booster shots, millions of Americans under 65 may find ...

Fierce Biotech1d

Moderna withdraws FDA filing for flu/COVID combination vaccine, plans resubmission with efficacy data

Moderna filed for FDA approval of its mRNA-1083 combination shot last year. The submission put the biotech on track to win ...

2don MSN

FDA to Unveil Covid Shot Policy as RFK Jr. Eyes More Tests

President Donald Trump’s administration is slated to lay out its approach to Covid vaccination at an event Tuesday that could ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results